Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 11:04:43 GMT 2023
by
admin
on
Sat Dec 16 11:04:43 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
JEA93WJ5DG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C133877
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
768220
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
830321
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
||
|
FDA ORPHAN DRUG |
726619
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2305607-45-6
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
PRIMARY | |||
|
C123734
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
PRIMARY | |||
|
JEA93WJ5DG
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
PRIMARY | |||
|
JK-152
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
PRIMARY | |||
|
11472
Created by
admin on Sat Dec 16 11:04:43 GMT 2023 , Edited by admin on Sat Dec 16 11:04:43 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_147 | 1_203 |
| 1_223 | 3_215 |
| 1_229 | 2_229 |
| 1_232 | 2_232 |
| 1_264 | 1_324 |
| 1_370 | 1_428 |
| 2_22 | 2_96 |
| 2_147 | 2_203 |
| 2_223 | 4_215 |
| 2_264 | 2_324 |
| 2_370 | 2_428 |
| 3_23 | 3_88 |
| 3_135 | 3_195 |
| 4_23 | 4_88 |
| 4_135 | 4_195 |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_58 |
| N | 1_300 |
| N | 2_58 |
| N | 2_300 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Agonist of the cell surface receptor CD40, with potential immunostimulatory and antineoplastic activities.
AGONIST
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|